Sign in
4

Changes in Ownership

Taysha Gene Therapies, Inc. Filed Acc 0001415889-25-015573

Director acquired 56,623 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Donenberg Phillip B. Director 2025-06-02 Grant or award +56,623 219,954 D
Derivatives
Donenberg Phillip B. Director 2025-06-02 Grant or award · Stock Option (right to buy) +113,246 113,246 D
Loading xslF345X05/form4-06042025_040607.xml…